USA – Tioga Cardiovascular, a Los Gatos, CA-based company that aims to redefine structural heart valve replacement, raised $30M in Series A funding.
The round was led by Cormorant Asset Management, with participation from The Capital Partnership, AMED Ventures, the PA MedTech VC Fund, and Shifamed angel investors.The company intends to use the funds to continue product development, support pre-clinical testing, and initiate in-human use for its novel transseptal mitral valve replacement (TMVR) technology.Led by Mike Dineen, President and CEO, Tioga Cardiovascular is focused on providing valve replacement solutions for mitral and tricuspid applications that are procedurally simpler.09/02/2023
